These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9639444)

  • 21. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases.
    Radu RA; Han Y; Bui TV; Nusinowitz S; Bok D; Lichter J; Widder K; Travis GH; Mata NL
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4393-401. PubMed ID: 16303925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye.
    Lewis KC; Zech LA; Phang JM
    Eur J Cancer; 1996 Sep; 32A(10):1803-8. PubMed ID: 8983293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attempts to define the minimal serum level of vitamin A required for normal visual function in a patient with severe fat malabsorption.
    Wachtmeister L; Björkhem I; Diczfalusy U; Emami A
    Acta Ophthalmol (Copenh); 1988 Jun; 66(3):341-8. PubMed ID: 10994458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints.
    Decensi A; Formelli F; Torrisi R; Costa A
    J Cell Biochem Suppl; 1993; 17G():226-33. PubMed ID: 8007703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rod-cone interaction in patients with fundus flavimaculatus.
    Schneider T; Zrenner E
    Br J Ophthalmol; 1987 Oct; 71(10):762-5. PubMed ID: 3676146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
    Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
    Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term tolerability of fenretinide (4-HPR) in breast cancer patients.
    Rotmensz N; De Palo G; Formelli F; Costa A; Marubini E; Campa T; Crippa A; Danesini GM; Delle Grottaglie M; Di Mauro MG
    Eur J Cancer; 1991; 27(9):1127-31. PubMed ID: 1835622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
    Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
    J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring rod and cone dynamics in age-related maculopathy.
    Dimitrov PN; Guymer RH; Zele AJ; Anderson AJ; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):55-65. PubMed ID: 18172075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
    Smith JE; Lawless DC; Green MH; Moon RC
    J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinol-binding protein secretion from the liver of N-(4-hydroxyphenyl) retinamide-treated rats.
    Ritter SJ; Smith JE
    Biochim Biophys Acta; 1996 Jun; 1290(2):157-64. PubMed ID: 8645719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoids, breast cancer and NK cells.
    Villa ML; Ferrario E; Trabattoni D; Formelli F; De Palo G; Magni A; Veronesi U; Clerici E
    Br J Cancer; 1993 Nov; 68(5):845-50. PubMed ID: 8217599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin-A reversal of abnormal dark adaptation in cirrhosis. Study of effects on the plasma retinol transport system.
    Russell RM; Morrison SA; Smith FR; Oaks EV; Carney EA
    Ann Intern Med; 1978 May; 88(5):622-6. PubMed ID: 565608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy.
    Owsley C; McGwin G; Jackson GR; Kallies K; Clark M
    Ophthalmology; 2007 Sep; 114(9):1728-35. PubMed ID: 17822978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration.
    Mata NL; Lichter JB; Vogel R; Han Y; Bui TV; Singerman LJ
    Retina; 2013 Mar; 33(3):498-507. PubMed ID: 23023528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness of dark-adaptation threshold to vitamin A and beta-carotene supplementation in pregnant and lactating women in Nepal.
    Congdon NG; Dreyfuss ML; Christian P; Navitsky RC; Sanchez AM; Wu LS; Khatry SK; Thapa MD; Humphrey J; Hazelwood D; West KP
    Am J Clin Nutr; 2000 Oct; 72(4):1004-9. PubMed ID: 11010944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.